{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T03:45:25Z","timestamp":1762746325140},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[1991,2]]},"DOI":"10.1016\/s0196-0644(05)81222-3","type":"journal-article","created":{"date-parts":[[2005,8,20]],"date-time":"2005-08-20T01:29:38Z","timestamp":1124501378000},"page":"194-197","source":"Crossref","is-referenced-by-count":17,"title":["Drug-induced supraventricular tachycardia: A case report of fluoxetine"],"prefix":"10.1016","volume":"20","author":[{"given":"Stephanie F","family":"Gardner","sequence":"first","affiliation":[]},{"given":"William F","family":"Rutherford","sequence":"additional","affiliation":[]},{"given":"Mark A","family":"Munger","sequence":"additional","affiliation":[]},{"given":"Edward A","family":"Panacek","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0196-0644(05)81222-3_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00003495-198632060-00002","article-title":"Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness","volume":"32","author":"Benfield","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/S0196-0644(05)81222-3_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cpt1978234421","article-title":"Fluoxetine, a selective serotonin uptake inhibitor","volume":"23","author":"Lemberger","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0196-0644(05)81222-3_bib3","first-page":"14","article-title":"Fluoxetine: Clinical pharmacology and physiologic disposition","volume":"46","author":"Lemberger","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0196-0644(05)81222-3_bib4","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1097\/00004714-198712001-00004","article-title":"Serotonin reuptake blockers in vitro and in vivo","volume":"7","author":"Fuller","year":"1987","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/S0196-0644(05)81222-3_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.1875-9114.1987.tb03496.x","article-title":"Fluoxetine: A serotonin-specific, second-generation antidepressant","volume":"7","author":"Sommi","year":"1987","journal-title":"Pharmacotherapy"},{"key":"10.1016\/S0196-0644(05)81222-3_bib6","first-page":"7","article-title":"The pharmacologic profile of fluoxetine","volume":"46","author":"Stark","year":"1985","journal-title":"J Clin Psychiatr"},{"key":"10.1016\/S0196-0644(05)81222-3_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0041-008X(86)90439-4","article-title":"Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogs","volume":"82","author":"Steinberg","year":"1986","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/S0196-0644(05)81222-3_bib8","series-title":"Package insert, formulary information on fluoxetine (Prozac\u00ae)","year":"1989"},{"key":"10.1016\/S0196-0644(05)81222-3_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.CIR.60.5.1045","article-title":"The electrocardiograhic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations","volume":"5","author":"Giardina","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/S0196-0644(05)81222-3_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/15563658108990022","article-title":"Cardiac arrhythmias and ECG abnormalities in tricyclic antidepressant overdose","volume":"18","author":"Fasoli","year":"1981","journal-title":"Clin Toxicol"},{"key":"10.1016\/S0196-0644(05)81222-3_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0196-0644(89)80566-9","article-title":"Terminal 40-ms frontal plane QRS axis as a marker for tricyclic antidepressant overdose","volume":"18","author":"Wolfe","year":"1989","journal-title":"Ann Emerg Med"},{"key":"10.1016\/S0196-0644(05)81222-3_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/15563658108990281","article-title":"Incidence of late arrhythmias following tricyclic antidepressant overdose","volume":"18","author":"Pentel","year":"1981","journal-title":"Clin Toxicol"},{"key":"10.1016\/S0196-0644(05)81222-3_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2165\/00003495-197408060-00007","article-title":"Cardiovascular complications of tricyclic antidepressant overdosage","volume":"8","author":"Burrows","year":"1974","journal-title":"Drugs"},{"key":"10.1016\/S0196-0644(05)81222-3_bib14","first-page":"42","article-title":"Effect of fluoxetine on the electrocardiogram","volume":"46","author":"Fisch","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0196-0644(05)81222-3_bib15","first-page":"59","article-title":"The side effect profile and safety of fluoxetine","volume":"46","author":"Wernicke","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0196-0644(05)81222-3_bib16","series-title":"Abstracts of the APhA Academy of Pharmaceutical Sciences 130th National Meeting","article-title":"Fluoxetine single dose- multiple-dose kinetics","author":"Bergstrom","year":"1985"},{"key":"10.1016\/S0196-0644(05)81222-3_bib17","series-title":"Abstracts of the APhA Academy of Pharmaceutical Sciences 133rd Annual Meeting and Exposition","article-title":"Fluoxetine steady-state pharmacokinetics in depressed patients","author":"Bergstrom","year":"1986"},{"key":"10.1016\/S0196-0644(05)81222-3_bib18","first-page":"2778","article-title":"The role of descending monoaminergic systems in central control of blood pressure","volume":"40","author":"Loewy","year":"1981","journal-title":"Fed Proc"},{"key":"10.1016\/S0196-0644(05)81222-3_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0002-9149(78)90009-7","article-title":"Central neurochemical factors related to serotonin metabolism and cardiac vulnerability for repetitive electrical activity","volume":"41","author":"Rabinowitz","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0196-0644(05)81222-3_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.HYP.2.3.243","article-title":"Review of the role of the central serotoninergic neural system in blood pressure regulation","volume":"2","author":"Kuhn","year":"1980","journal-title":"Hypertension"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064405812223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064405812223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:24:10Z","timestamp":1548188650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064405812223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,2]]}},"alternative-id":["S0196064405812223"],"URL":"https:\/\/doi.org\/10.1016\/s0196-0644(05)81222-3","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[1991,2]]}}}